文献速递临床试验与 GCP真实世界研究与卫生经济

渐进式个体化步行与教育项目预防成人腰痛复发的有效性与成本效果:WalkBack随机对照试验统计分析计划

Effectiveness and cost-effectiveness of a progressive, individualised walking and education program for prevention of low back pain recurrence in adults: statistical analysis plan for the WalkBack randomised controlled trial.
PubMed 文献 · Trials · 2023-03-16

WalkBack是一项前瞻性注册的实用性随机对照试验,比较6个月渐进式个体化步行与教育项目与不治疗对照组预防腰痛复发的有效性与成本效果。主要结局为首次活动受限性腰痛复发的时间,所有参与者随访至少12个月,分析遵循意向性治疗原则。

要点

  • WalkBack试验评估6个月渐进式个体化步行与教育项目对比不治疗对照组预防腰痛复发的效果。
  • 主要结局为首次活动受限性腰痛复发的时间,关键次要结局包括任何复发时间、因腰痛就诊复发时间、残疾水平、健康相关生活质量、腰痛相关费用及不良事件。
  • 统计分析计划采用Cox回归评估复发时间结局,计算风险比和中位生存时间及95%置信区间,连续结局采用重复测量线性混合模型。

核心结论

  • WalkBack试验将提供步行干预预防腰痛复发的有效性与成本效果证据,本统计分析计划使试验分析具有透明度。

研究设计与样本

  • WalkBack是一项前瞻性注册的实用性随机对照试验,比较6个月渐进式个体化步行与教育项目(干预组)与不治疗对照组,所有参与者随访至少12个月。
  • 分析遵循意向性治疗原则;计划采用Cox回归评估活动受限性、轻微及因就诊复发的复发时间结局,计算风险比和中位生存时间及95%置信区间。
  • 连续结局的干预效果采用重复测量线性混合模型估计;从社会视角对预防复发(是/否)和质量调整生命年进行经济学评价;组间不良事件比例采用Fisher精确检验比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Exercise for the prevention of low back pain recurrences is recommended, but under-researched. The effectiveness and cost-effectiveness of a walking program for preventing low back pain recurrence remains unknown. This a priori statistical analysis plan describes the methods of analysis for the WalkBack trial. METHODS: WalkBack is a prospectively registered, pragmatic, randomised controlled trial. The aim is to investigate the effectiveness and cost-effectiveness of a 6-month progressive and individualised walking and education program (intervention) for the prevention of low back pain recurrences, compared to a no-treatment control group. The primary outcome is days to the first recurrence of an episode of activity-limiting low back pain. Key secondary outcomes include days to any recurrence of low back pain, days to a care-seeking recurrence of low back pain, disability level, health-related quality of life, costs associated with low back pain and adverse events. All participants will be followed for a minimum of 12 months. Analysis will follow the intention-to-treat principle. Cox regression is planned to assess the effects for the outcomes of time to activity-limiting, minimal and care-seeking recurrence. Hazard ratios and median survival times with 95% confidence intervals will be calculated. The effect of the intervention on continuous outcomes will be estimated with repeated-measure linear mixed models. An economic evaluation will be performed from the societal perspective for recurrence prevented (yes/no) and quality-adjusted life years. The proportion of adverse events between groups will be compared using Fisher's exact test. DISCUSSION: The WalkBack trial will provide evidence on the effectiveness and cost-effectiveness of a walking intervention to prevent low back pain recurrences. This statistical analysis plan provides transparency on the analysis of the trial. TRIAL REGISTRATION: WalkBack - Effectiveness and cost-effectiveness of a progressive individualised walking and education program for the prevention of a recurrence of low back pain. ACTRN12619001134112 . Date Registered: 14/08/2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Pocovi NC, Graham PL, Lin CC, et al. Effectiveness and cost-effectiveness of a progressive, individualised walking and education program for prevention of low back pain recurrence in adults: statistical analysis plan for the WalkBack randomised controlled trial. Trials. 2023. PMID: 36927497. doi:10.1186/s13063-023-07119-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。